Programme

07:00-17:00 Registration DKMS Symposium
Click to view/download program
Venue: Boardroom 1-2
08:30-10:00 BREAKFAST SYMPOSIUM
MSD
Advances in the treatment options and outcomes for melanoma patients – changing the role of the MDT
Dr Dagmar Whitaker
Prof Alexander Eggermont
Dr Sze Wai Chan

Venue: Bill Gallagher

 

Session 1: Joint Plenary
Covid Track
Chairs: Prof Paul Ruff and Prof Vernon Louw

Venue: Ballroom 2-4

10.30-10:40 Opening
Dr Devan Moodley and Dr Michael Cass
10:40-11:20 The impact of Covid-19 on Oncology
Prof Georgia Demetriou
11:20-12:00 Covid-19 Vaccination in Oncology
Prof Shabir Madhi
12:00-12:40 Rituximab use during the Pandemic
Prof Alexander Egle
12:40-13:00 Panel discussion / Q&A
13:00-14:00 LUNCH SYMPOSIUMS
Pfizer
The era of CDK4/6 inhibitors in the management of ER+, HER2- breast cancer: Evidence and future opportunities
Professor Giuseppe Curigliano

Venue: Bill Gallagher

Sanofi
Approach to the management of multiple myeloma
Prof Mohamad Mohty
Chair: Dr Michael Cass

Venue: Committee 4

14:00-15:30 Session 2 Breast Track
Chairs: Prof Georgia Demetriou and Dr Dineo Tshabalala

Venue: Ballroom 2-3

SASCeTS: Allogeneic Donor Selection Session
Chair: Prof Estelle Verburgh

Venue: Ballroom 4

14:00-14:30 Importance of the CDK4/6i therapy and treatment sequencing
Dr Mark Verill
Donor selection – a complex decision requiring the weighing of a multitude of factors
Prof Martin Bornhauser
14:30-15:00 Chemotherapy for Luminal MBC
Dr Mark Verrill
15:00-15:30 Life after CDK4/6I
Dr Peter Fasching
A practical approach to donor selection in the South African context
Prof Matthew Seftel
15:30-16:00 REFRESHMENT BREAK
16:00-18:00 SASMO Conference SASCeTS Conference
Session 3 Tumour Agnostic Session
Chair: Dr Daleen Geldenhuys and Dr Omondi Ogude
SASCeTS: Allogeneic Transplantation
Chair: Dr Pieter de Witt
16:00-16:30 Introducing PARPi inhibitors
Dr Susana Banerjee
Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?
Dr Justin du Toit
16:30-17:00 Tumour Encyclopaedic Analysis
Dr Chirantan Bose
Debate:
Autologous vs Allogeneic Transplant for T-cell lymphomas
Dr Farah Rahman vs Dr Siphiwe Baloyi
17:00-17:40 The Neo-adjuvant Immunotherapy Revolution
Prof Alexander Eggermont
Management of steroid-resistant Graft vs Host disease
Prof Robert Zeiser
17:40-18:10 Advances in IO and future directions
Prof Bernardo Rapoport
18:10 – 18:45
SASMO AGM
18:00 – 18:30
SASCeTS AGM
18:45-21:30 Exhibitors Welcome Cocktail
07:00-17:00 Registration
07:30-08:30 BREAKFAST SYMPOSIUMS

Takeda
Redefining ALK positive NSCLC Management
Chair: Dr Omondi Ogude and Dr Ronwyn Van Eeden

Venue: Boardroom 6-7

AbbVie
Can we do better for our AML patients?
Chair:Dr Lucille Singh
Dr Ofir Wolach

Venue: Boardroom 1-2

Session 4: Joint Plenary
Chairs: Prof Bernardo Rapoport & Dr David Brittain
Venue: Ballroom 2-4

09:00-09:05 Opening of Plenary Prof Bernardo
Rapoport & Dr David Brittain
09:05-09:35 Hematopoietic Stem Cell Transplantation in Multiple myeloma: Current Status & future direction Prof Mohamad Mohty
09:35-10:05 Management of the cancer patient in the era of covid-19 Prof Giuseppe Curigliano
10:05-10:45 Research in Africa Dr Patrick Soon-Shiong
10:45-11:05 Cryopreservation and Cancer – Fertility Preservation for AYAs Kristin Smith
11:05-11:30 REFRESHMENT BREAK
11:30-13:00 TRACKS

SASMO

Venue: Ballroom 2-3

SASCETS

Venue: Ballroom 4

SASOPh –
PHARMACISTS

Venue: Committee 2

SASREG

Venue: Committee 4

NURSES SYMPOSIUM
Sponsored by Novartis

Venue: Bill Gallagher

Session 5: Git Track
Chairs: Dr Ashraf Wadee and Dr Mariza Tunmer
CAR T-cell sessions
Chair:
Prof Vernon Louw
Chair: Dr Johannes van Waart
11:30-12:00 Colon Ca Talk
Prof Dirk Arnold
CAR T-cells in ALL and DLBCL – an
update on the trials
Dr Partow Kebriaei
11h30-12h15
Fundamentals of Oncology
Tegan Bilse
The Oncofertility Network in South African: A progress report
Dr Chris Venter
11:30 – 12:30
VIKING Apheresis Workshop
Chair: Eileen Claassens
12:00-12:20 The clinical value of NGS and its impact on healthcare in cancer
Professor Andrew Beggs
12h15-13h00
Immunotherapy
Teresa Smith
Fertility Risk Stratification
Kristen Smith
12:20-13:00 Surgical Talk in
mCRC/HPB
Prof Jean Botha
CAR T-Cells in the treatment of multiple myeloma
Prof Sham Malainkody

Fertility Preservation in Breast cancer: Stimulation, risk and outcomes.
Dr Johannes van Waart

13:00 – 13:30
Discussions

12:30 – 13:00
Haematology Course
Caroline Rich, Igazi
13:00-14:00 LUNCH SYMPOSIUMS

Novartis
“Precision medicine, a new era with PI3K inhibitors’
Dr Peter Fasching

Venue: Boardroom 6 -7

Janssen
Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy? Prof Francesc Bosch

Venue: Boardroom 1-2

14:00-15:40 TRACKS
SASMO SASCETS SASOPh –
PHARMACISTS
SASREG NURSES SYMPOSIUM
Sponsored by Novartis
Session 6: Lung
Track
Chairs: : Dr Sze-Wai Chan and Dr Duvern Ramiah
SASCeTS CAR T-Cell Sessions
Chair: Prof Vernon Louw
14h00-14h45
Answering your GP’s question, the Drug interaction
Johan Labuschagne
  Chair:
Eileen Claassens
14:00-14:30 Lung Cancer Mutational assessment:
Prof Simon
Nayler
CAR T-cells – alternatives to the commercially available platforms
Dr Urbano

Pre-Pubertal Fertility Preservation and Hormone restoration
Prof Monica Laronda
Chair: Dr Nicholas Clark

14:30 – 15:30
Dialogues in Oncofertility: Case Studies
Chair: Dr Chris Venter

Panel: Kristen Smith
Prof Monica Laronda
Dr Tegan van Eeden
Dr Nadia Berringer
Prof Carol Benn
Adelle Van der Walt

14:00 – 14:30
MDS/CASTELEMANS/MM
Andrea Brummer
14:30-15:10 The evolution of IO from Melanoma through to lung cancer:
Prof Alexander
Eggermont
14h45-15h30
Oral chemotherapy
Carien v.d. Merwe

14:30 – 15:30
Being Care-FULL
Pieter Le Roux
Chair:
Andrea Brummer

15:10-15:40 Searching for a drugable target:
Prof Ross Camidge
CAR T-cells in the South African context
Dr David Brittain
15h30-16h00
Advancing Oncology Pharmacy Education:
The Wits Pharmacy Experience

Razeeya Khan
  15:30 – 15:50
Leucophoresis
Sr Murial Wentzel
15:40-16:00 REFRESHMENT BREAK
16:00-17:00 TRACKS
SASMO
Chairs: Dr Yusuf Mayet and Dr Mia Hugo
SASCeTS SASOPh –
PHARMACISTS
SASREG NURSES SYMPOSIUM
Sponsored by Novartis
16:00-16:40

Her2 Breast cancer: Where to next?

Prof Hope Rugo

Proffered Papers
Chair: Dr Sharlene Parasnath
16h00-16h45
Transplantation and HD chemotherapy
Dr Michael Cass
16h45 – 17h00
Handover of Michael Conidaris Trophy Karin Robinson

15:50 – 16:10
Prevention of infection in the immune-compromised patient
Eileen Claasens

16:30 – 17:00
AICF Oncology Nurse Curriculum

Vivian Katzaf

17:00 – 17:30
Defending the Gut in its ongoing failures and symptoms caused by Haematological treatments.

Zelda Hugo

17:30 – 18:00
The psychosocial impact of graft vs host disease and their families

Avril de Beer

16:40-17:00 Session 7:
Proffered Papers
17:00-18:00 MEET THE EXPERTS SESSIONS
Janssen
Is earlier better? Management of Advanced Prostate Cancer with Novel Therapies (Novel agents in mHSPC with thoughts on doublet vs triplet and adjuvant therapies
Prof Amit Bahl
Venue: Boardroom 1-2

Roche
What else for the HER2+ BC patient
Prof Hope Rugo

Venue: Committee 2

Janssen
Dr Francesc Bosch

Venue: Boardroom 6 – 7

19:00-22:30 CONGRESS DINNER
 

Session 7: Joint Plenary
Chairs: Dr Richard Kanyile and Dr Michael Cass

08:00 – 08:40 Chemotherapy in a pandemic  Prof Hope Rugo
08:40-09:00 Managed Health care services in Oncology Dr Ryan Noach
09:00-10:00 BRUNCH SYMPOSIUM
  Lilly 
Treating aggressive MBC and patient outcomes
Dr Mark Verril

Venue : Boardroom 6 – 7

Proferred Papers
Chair:  Dr Vinitha Philip
10:00-10:30  REFRESHMENT BREAK 
10:30-12:00 SASMO SASCeTS
Session 8:  UGT 
Chairs: Dr Adnaan Variava and Dr Rob De Bruyne
SASCeTS: Enhancing collaboration in South Africa
Chair: Dr Karen Gunther
10:30-11:10 Systemic therapy for Prostate Cancer
Prof Bertrand Tombal
Quality Management
Introduction: The benefits of a quality management programme
Dr Andrew McDonald 
Starting a quality management programme 
Dr Jackie Thomson 
Analysis of QM in HSCT in SA
Sr Carole Charly 
Discussion:
How can Haematology Centres collaborate with one another to establish quality management programmes?
11:10-11:30 Surgery in prostate cancer
Prof Shingai Mtambirwa
11:30-11:50  Radiotherapy in UGT
Dr Sheynaz Bassa
Collaboration between Blood SA and SASCeTS
Prof Estelle Verburgh
11:50-12:00 Closing Address Prize Presentation SASCeTS Closing and prize presentation